Thiazolidinedione
Thiazolidinedione is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Integrating the Genetic and Metabolic Faces of Obesity
A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus
Islet Transplantation in Type 1 Diabetic Patients
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
Clinical Trials (5)
Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Integrating the Genetic and Metabolic Faces of Obesity
A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus
Islet Transplantation in Type 1 Diabetic Patients
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5